3 reports

  • DIABETES AND OBESITY THERAPEUTICS MARKET, GLOBAL, ANNUAL REVENUE FORECAST FOR GLP1R
  • DIABETES AND OBESITY THERAPEUTICS MARKET, GLOBAL, ANNUAL REVENUE FORECAST FOR
  • Gliptins
  • World
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Novo Nordisk Group
  • DPP4 INHIBITORS: DISTRIBUTION BY DOSAGE FREQUENCY
  • 11.4.1. PUBLICATIONS ON DPP4 INHIBITORS: DISTRIBUTION BY
  • Gliptins
  • Market Size
  • Boehringer Ingelheim GmbH
  • Eli Lilly & Co.
  • Sanofi S.A.

DPP IV Inhibitors

4091 4500 3477

Gliptins II-## Huge Potential Exists for Januvia and Other DPP-## Inhibitors II-## Table ##: Global DPP-## Inhibitor Market by Top Five Drug Class (2015): Percentage Market Share Breakdown of Revenues (includes corresponding Graph/ Chart) II-## The Diabetes Epidemic..............

  • Gliptins
  • Asia
  • United States
  • World
  • Company Sales